IMMUNOPROPHYLAXIS OF SEVERE RESPIRATORY-SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: RESULTS OF 4 EPIDEMIC SEASONS

QR Code

IMMUNOPROPHYLAXIS OF SEVERE RESPIRATORY-SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: RESULTS OF 4 EPIDEMIC SEASONS

Children with bronchopulmonary dysplasia belong to the risk group of severe respiratory-syncytial viral infection (RSV). World experience and authors' own clinical data show that seasonal immunoprophylaxis of RSV infection's severe course by palivizumab in these patients allows reducing fr...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. A. Baranov, I. V. Davydova, T. V. Turti, L. S. Namazova-Baranova, V. V. Altunin, E. P. Zimina, E. V. Pavlyukova
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2012-12-01
Series:	Педиатрическая фармакология
Subjects:	respiratory-syncytial virus bronchopulmonary dysplasia acute respiratory viral infection respiratory function palivizumab
Online Access:	https://www.pedpharma.ru/jour/article/view/268
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunoprophylaxis of Respiratory Syncytial Virus Infection in Children
by: A. A. Baranov, et al.
Published: (2015-12-01)

PREVENTIVE STRATEGIES IN THE STAGES OF FORMATION AND COURSE OF BRONCHOPULMONARY DYSPLASIA
by: I. V. Davydova, et al.
Published: (2014-03-01)

MUCOLYTICS IN BRONCHOPULMONARY DYSPLASIA THERAPY
by: I. V. Davydova, et al.
Published: (2012-10-01)

IMMUNOPTOPHYLAXIS OF THE RESPIRATORY SYNCYTIAL VIRAL INFECTION IN CHILDREN UNDER RISK OF HEAVY COURSE OF THE DISEASE: PRELIMINARY RESULTS OF IMPLEMENTING THE MOSCOW PROGRAM
by: A. A. Korsunskiy, et al.
Published: (2012-06-01)

Modern Approaches in management of Children with Acute Bronchiolitis
by: Alexander A. Baranov, et al.
Published: (2020-02-01)

Respiratory syncytial virus immunization in children: The old, the new and what’s just around the corner
by: Bosco A. Paes, et al.
Published: (2025-12-01)

Clinical course of children with postinfectious bronchiolitis obliterans with versus without comorbid bronchopulmonary dysplasia
by: Lamia Medghoul, et al.
Published: (2025-07-01)

Treatment and prophylaxis of moderate and severe bronchopulmonary dysplasia in premature neonates
by: A.V. Bolonska, et al.
Published: (2021-09-01)

A CLINICAL AND ECONOMICAL ANALYSIS OF THE RESULTS PRODUCED BY THE PROGRAM OF RSV-INFECTION PROPHYLAXIS DURING THE EPIDEMIOLOGICAL SEASON OF 2012/2013 IN MOSCOW
by: V. I. Ignat'eva, et al.
Published: (2013-11-01)

FUNCTIONAL ASSESSMENT OF RESPIRATORY DISORDERS IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA DURING FOLLOW-UP
by: I. V. Davydova, et al.
Published: (2014-11-01)

IMMUNE PREVENTION OF RESPIRATORY-SYNCYTIAL VIRAL INFECTION: 15 YEARS OF WORLD EXPERIENCE
by: E. S. Keshishyan
Published: (2013-07-01)

CLINICAL AND PATHOMORPHOLOGICAL MANIFESTATIONS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION. CASE REPORT
by: I. V. Babachenko, et al.
Published: (2018-04-01)

Characteristics of respiratory syncytial virus infection in children in Pudong New Area， Shanghai， 2013‒2023
by: YU Qiumiao, et al.
Published: (2025-05-01)

Immunoprophylaxis of infectious diseases in premature infants
by: Alexander A. Baranov, et al.
Published: (2018-12-01)

Metabolic Reprogramming in Respiratory Viral Infections: A Focus on SARS-CoV-2, Influenza, and Respiratory Syncytial Virus
by: Jordi Camps, et al.
Published: (2025-07-01)

Generation of nanobodies against the F protein of respiratory syncytial virus and establishment of an indirect immunofluorescence assay
by: Qianqian Wang, et al.
Published: (2025-07-01)

THE EFFICACY OF THE COSTS ON SEVERE RESPIRATORY SYNCYTIAL INFECTION PREVENTION WITH PALIVIZUMAB IN PRETERM INFANTS
by: A. V. Rudakova, et al.
Published: (2012-07-01)

Epidemiological and Clinical Characteristics of Respiratory Syncytial Virus Infection in Children in Hangzhou (2022–2023)
by: Qin-Rui Lai, et al.
Published: (2025-06-01)

Bronchopulmonary Dysplasia in Post-Surfactant Era: Results of an Objective Assessment of the Disease
by: I. V. Davydova, et al.
Published: (2015-09-01)

The promise and progress of RNA-interference-based antiviral therapy for respiratory syncytial virus.
by: V. V. Vysochinskayа, et al.
Published: (2014-09-01)

Enteroviruses in the etiology of acute respiratory viral infections in children, Novosibirsk, Russia
by: O. G. Kurskaya, et al.
Published: (2024-01-01)

Bronchopulmonary Dysplasia: a Modern View on Course and Outcomes
by: K. A. Kazakova
Published: (2016-11-01)

Extrapulmonary Conditions, Concomitant of Bronchopulmonary Dysplasia, in Babies of the First 3 Years of Life: Results of a Retrospective Cross-Sectional Study
by: K. A. Kazakova, et al.
Published: (2016-12-01)

Broncho-phonography as a method for predicting the outcome of respiratory distress syndrome in preterm infants
by: Ye. B. Pavlinova, et al.
Published: (2011-08-01)

Seroprevalence of RSV IgG Antibodies Across Age Groups in Poland After the COVID-19 Pandemic: Data from the 2023/2024 Epidemic Season
by: Barbara Poniedziałek, et al.
Published: (2025-07-01)

Severity of Respiratory Viral Diseases and the Impacts of Underlying Medical Conditions During the Omicron Subvariant Dominant Epidemics—A Comparative Study of SARS-CoV-2, Influenza Virus and Respiratory Syncytial Virus
by: Yu Jung Choi, et al.
Published: (2025-05-01)

Research hotspots and global trends in respiratory syncytial virus over past five years
by: Xiaoli Tao, et al.
Published: (2025-08-01)

Application broncho-phonography investigation for an estimation of respiratory frustration at immature infants with a respiratory distress-syndrome
by: Ye. B. Pavlinova, et al.
Published: (2010-06-01)

Assessment of Safety, Immunogenicity and Preventive Efficacy of Prevenar-13 in Children with Bronchopulmonary Dysplasia
by: E. S. Zubova, et al.
Published: (2018-04-01)

MUCOLYTIC THERAPY IN INFANTS
by: I. V. Davydova, et al.
Published: (2013-09-01)

Respiratory Syncytial Virus Vaccine Induced Thrombotic Microangiopathy
by: Seby R, et al.
Published: (2025-07-01)

Burden of respiratory syncytial virus disease in infants and the potential value of maternal immunization in Greece
by: George Gourzoulidis, et al.
Published: (2025-07-01)

Genetic Determination of Bronchopulmonary Dysplasia Formation: Pros and Cons
by: V. K. Pozharishchenskaya, et al.
Published: (2017-05-01)

Bronchopulmonary dysplasia in children: clinical and anamnestic aspects of cytokine gene polymorphisms
by: S. V. Suprun, et al.
Published: (2025-01-01)

Prophylaxis of respiratory syncytial virus infection: current status and prospects for vaccine development
by: A. S. Korovkin, et al.
Published: (2024-10-01)

RISK FACTORS OF BRONCHOPULMONARY DYSPLASIA DEVELOPMENT IN NEONATES WITH VERY LOW AND EXTREMELY LOW BIRTH WEIGHT
by: O. V. Lebedeva
Published: (2014-05-01)

Current status of developments in the field of respiratory syncytial virus vaccines
by: Tatiana S. Kotomina
Published: (2025-05-01)

Characterisation of the respiratory syncytial virus seasonality and its environmental factors in the Americas—a multi-country observational study using routine surveillance networksResearch in context
by: Paula Couto, et al.
Published: (2025-08-01)

Respiratory Syncytial Virus Infection. Pathogenesis Peculiarities, Prevention and Treatment Strategies
by: V. Z. Krivitskaya
Published: (2013-03-01)

Public health impact of nirsevimab against acute lower respiratory infections associated with respiratory syncytial virus among Chinese infants: a modelling study
by: Xiaozhen Lai, et al.
Published: (2025-12-01)